Wolverine Trading, LLC Bio N Tech Se Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Wolverine Trading, LLC holds 12,528 shares of BNTX stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,528

Previous 11,301 10.86%

Holding current value

$1.43 Million

Previous $908,000 63.77%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $96,147 - $152,957	1,227 Added 10.86%	12,528 $1.49 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $662,327 - $847,854	8,242 Added 269.43%	11,301 $908,000
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $128,636 - $162,458	-1,446 Reduced 32.1%	3,059 $282,000
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $52,818 - $65,507	-581 Reduced 11.42%	4,505 $475,000
Q3 2023 Nov 15, 2023	BUY	$98.5 - $125.08 $500,971 - $636,156	5,086 New	5,086 $552,000
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $230,346 - $361,867	1,945 Added 19.26%	12,043 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $1.4 Million - $2.01 Million	-10,979 Reduced 52.09%	10,098 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $241,693 - $365,216	-1,961 Reduced 8.51%	21,077 $2.99 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $90,521 - $166,236	717 Added 3.21%	23,038 $4.03 Million
Q2 2021 Aug 06, 2021	BUY	$113.32 - $241.49 $1.48 Million - $3.14 Million	13,018 Added 139.93%	22,321 $5.09 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $282,566 - $393,872	3,296 Added 54.87%	9,303 $972,000
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $436,768 - $778,146	6,007 New	6,007 $504,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Bio N Tech Se Transaction History